M-A: Long-acting injectable vs. oral antipsychotics for the maintenance treatment of schizophrenia

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry

Commentary on Twitter

"Taken together, the results suggest increased use of long-acting injectable antipsychotics in clinical practice should be considered."

New Researchhttps://t.co/l2Ow9BzCUu

— The Lancet Psychiatry (@TheLancetPsych) April 14, 2021